[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Clinuvel Pharmaceuticals Ltd ADR (CUVL)

Clinuvel Pharmaceuticals Ltd ADR (CUVL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 0
  • Shares Outstanding, K 0
  • Annual Sales, $ 95,018 K
  • Annual Income, $ 36,173 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales 5.61
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.20 +9.19%
on 08/03/26
8.20 -17.44%
on 08/24/26
-0.24 (-3.42%)
since 07/27/26
3-Month
6.19 +9.32%
on 06/10/26
8.20 -17.44%
on 08/24/26
+0.21 (+3.20%)
since 05/27/26
52-Week
5.98 +13.21%
on 05/19/26
8.92 -24.10%
on 12/29/25
-1.99 (-22.70%)
since 08/27/25

Most Recent Stories

More News
A decade of profitability provides foundation for CLINUVEL’s U.S. expansion

CLINUVEL PHARMACEUTICALS LTD announced its tenth consecutive annual profit and further rise in free cash in the financial year ended 30 June 2026...

CUVL : 6.77 (-11.44%)
CLVLY : 7.3500 (+3.09%)
CUV.AX : 8.660 (-5.66%)
CLINUVEL implements strategic reorganisation to refocus on U.S. markets

MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic...

CUVL : 6.77 (-11.44%)
CLVLY : 7.3500 (+3.09%)
CUV.AX : 8.660 (-5.66%)

Business Summary

CLINUVEL PHARMACEUTICALS LIMITED is a biopharmaceutical company focused on developing and delivering innovative therapies for patients with genetic, metabolic and dermatological disorders. The Company's portfolio is centred around melanocortin peptides, with programs advancing in photomedicine and vitiligo....

See More

Key Turning Points

3rd Resistance Point 8.77
2nd Resistance Point 8.36
1st Resistance Point 7.57
Last Price 6.77
1st Support Level 6.37
2nd Support Level 5.96
3rd Support Level 5.17

See More

52-Week High 8.92
Fibonacci 61.8% 7.80
Fibonacci 50% 7.45
Fibonacci 38.2% 7.10
Last Price 6.77
52-Week Low 5.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.